不同类型膀胱炎的诊疗进展
Progress in the Diagnosis and Treatment of Different Types of Cystitis
DOI: 10.12677/acm.2024.1451516, PDF,   
作者: 武超越, 郝亮亮, 赵家伟, 马锦容：延安大学医学院，陕西 延安；靳永胜*：延安大学附属医院泌尿外科，陕西 延安
关键词: 膀胱炎；诊疗进展；膀胱炎的分型；腺性膀胱炎；Cystitis； Progress of Diagnosis and Treatment； Types of Cystitis； Glandular Cystitis
摘要: 泌尿系统疾病中，膀胱炎的发生率相当高，尤其在女性中更为常见。该病通常表现为血尿、排尿时疼痛、下腹部不适、频繁排尿和急迫感。如果治疗不当或延误，膀胱炎可能导致严重并发症，如附睾炎、阴道炎、尿道炎和急性肾盂肾炎等。诱发膀胱炎的因素众多，不同的原因会导致病情表现各异，治疗方法也因膀胱炎的类型而异。随着医疗科技的进步，对各类膀胱炎的诊断与治疗策略正日益优化。本文旨在通过对膀胱炎常见病因的分类整理，介绍其最新的诊疗动态，以促进治疗成效的提升，并依据患者独特情况制定个性化、精准的治疗计划。
Abstract: Cystitis stands as a prevalent condition within urological practice, particularly among females, characterized by symptoms such as hematuria, painful urination, lower abdominal discomfort, and urinary frequency and urgency. Untreated or delayed treatment of cystitis can lead to severe complications like epididymitis, vaginitis, urethritis, and acute pyelonephritis, posing a risk to patient health. The etiological factors of cystitis are multifaceted, with diverse clinical presentations and treatment modalities varying across cystitis classifications. Advances in medical technology have been refining the diagnostic and therapeutic approaches for different cystitis types. This review aims to categorize common etiologies of cystitis and present the advancements in their management, thereby enhancing treatment outcomes and tailoring precise, personalized therapeutic strategies for patients.
文章引用：武超越, 郝亮亮, 赵家伟, 马锦容, 靳永胜. 不同类型膀胱炎的诊疗进展[J]. 临床医学进展, 2024, 14(5): 990-997. https://doi.org/10.12677/acm.2024.1451516

参考文献

[1] Adelugba, I., Siddiqui, S., Aziz, A., et al. (2023) Interstitial Cystitis/Bladder Pain Syndrome: What Today’s Urologist should Know. Current Bladder Dysfunction Reports, 18, 16-28. [Google Scholar] [CrossRef] 
[2] Clemens, J.Q., Erickson, D.R., Varela, N.P. and Lai, H.H. (2022) Diagnosis and Treatment of Interstitial Cystitis/Bladder Pain Syndrome. Journal of Urology, 208, 34-42. [Google Scholar] [CrossRef] 
[3] Anger, J.T., Dallas, K.B., Bresee, C., De Hoedt, A.M., Barbour, K.E., Hoggatt, K.J., Goodman, M.T., Kim, J. and Freedland, S.J. (2022) National Prevalence of IC/BPS in Women and Men Utilizing Veterans Health Administration Data. Frontiers in Pain Research, 3, Article 925834. [Google Scholar] [CrossRef] [PubMed]
[4] Akiyama, Y., Luo, Y., Hanno, P.M., Maeda, D. and Homma, Y. (2020) Interstitial Cystitis/Bladder Pain Syndrome: The Evolving Landscape, Animal Models and Future Perspectives. International Journal of Urology, 27, 491-503. [Google Scholar] [CrossRef] [PubMed]
[5] Homma, Y., Akiyama, Y., Tomoe, H., Furuta, A., Ueda, T., Maeda, D., Lin, A.T., Kuo, H.C., Lee, M.H., Oh, S.J., Kim, J.C. and Lee, K.S. (2020) Clinical Guidelines for Interstitial Cystitis/Bladder Pain Syndrome. International Journal of Urology, 27, 578-589. [Google Scholar] [CrossRef] [PubMed]
[6] Windgassen, S. and McKernan, L. (2020) Cognition, Emotion, and the Bladder: Psychosocial Factors in Bladder Pain Syndrome and Interstitial Cystitis (BPS/IC). Current Bladder Dysfunction Reports, 15, 9-14. [Google Scholar] [CrossRef] [PubMed]
[7] Jabbari, B. (2018) Botulinum Toxin Treatment. Springer International Publishing, Cham. [Google Scholar] [CrossRef] 
[8] Jiang, Y.-H., Jhang, J.-F. and Kuo, H.-C. (2022) The Clinical Application of Intravesical Botulinum Toxin A Injection in Patients with Overactive Bladder and Interstitial Cystitis. Tzu Chi Medical Journal, 35, 31-37. [Google Scholar] [CrossRef] [PubMed]
[9] Simpson, L.L. (1980) Kinetic Studies on the Interaction Between Botulinum Toxin Type A and the Cholinergic Neuromuscular Junction. Journal of Pharmacology and Experimental Therapeutics, 212, 16-21.
[10] Giannantoni, A., Gubbiotti, M. and Bini, V. (2019) Botulinum Neurotoxin A Intravesical Injections in Interstitial Cystitis/Bladder Painful Syndrome: A Systematic Review with Meta-Analysis. Toxins, 11, Article 510. [Google Scholar] [CrossRef] [PubMed]
[11] Engeler, D., Bananowski, A.P., Berghmans, B., et al. (2019) EAU Guidelines on Chronic Pelvic Pain. European Association of Urology, Arnhem.
[12] Yu, W.-R., Jhang, J.-F. and Kuo, H.-C. (2024) Intravesical Botulinum Toxin Injection Plus Hydrodistention Is More Effective in Patients with Bladder Pain-Predominant Interstitial Cystitis/Bladder Pain Syndrome. Toxins, 16, Article 74. [Google Scholar] [CrossRef] [PubMed]
[13] 王伟, 杨建军, 杨关天, 等. 放射性膀胱炎的治疗进展[J]. 临床泌尿外科杂志, 2019, 34(6): 489-492. [Google Scholar] [CrossRef] 
[14] 巫嘉文, 余洋. 高压氧综合治疗出血性放射性膀胱炎56例疗效观察[J]. 中华航海医学与高气压医学杂志, 2016, 23(4): 323-325.
[15] Eastman, R., Leaf, E.M., Zhang, D., True, L.D., Sweet, R.M., Seidel, K., Siebert, J.R., Grady, R., Mitchell, M.E. and Bassuk, J.A. (2010) Fibroblast Growth Factor-10 Signals Development of Von Brunn’s Nests in the Exstrophic Bladder. American Journal of Physiology-Renal Physiology, 299, F1094-F1110. [Google Scholar] [CrossRef] [PubMed]
[16] Xin, Z., Zhao, C., Huang, T., Zhang, Z., Chu, C., Lu, C., Wu, M. and Zhou, W. (2016) Intestinal Metaplasia of the Bladder in 89 Patients: A Study with Emphasis on Long-Term Outcome. BMC Urology, 16, Article No. 24. [Google Scholar] [CrossRef] [PubMed]
[17] Li, R. and Leslie, S.W. (2023) Cystitis. StatPearls Publishing, Treasure Island.
[18] Reddy, M. and Zimmern, P.E. (2022) Efficacy of Antimicrobial Intravesical Treatment for Uncomplicated Recurrent Urinary Tract Infections: A Systematic Review. International Urogynecology Journal, 33, 1125-1143. [Google Scholar] [CrossRef] [PubMed]
[19] Sabih, A. and Leslie, S.W. (2023) Complicated Urinary Tract Infections. StatPearls Publishing, Treasure Island.
[20] Chiu, K., Zhang, F., Sutcliffe, S., Mysorekar, I.U. and Lowder, J.L. (2022) Recurrent Urinary Tract Infection Incidence Rates Decrease in Women with Cystitis Cystica after Treatment with D-Mannose: A Cohort Study. Female Pelvic Medicine & Reconstructive Surgery, 28, e62-e65. [Google Scholar] [CrossRef] 
[21] De Nunzio, C., Bartoletti, R., Tubaro, A., Simonato, A. and Ficarra, V. (2021) Role of D-Mannose in the Prevention of Recurrent Uncomplicated Cystitis: State of the Art and Future Perspectives. Antibiotics, 10, Article 373. [Google Scholar] [CrossRef] [PubMed]
[22] Yuksel, O.H., Urkmez, A., Erdogru, T. and Verit, A. (2015) The Role of Steroid Treatment in Intractable Cystitis Glandularis: A Case Report and Literature Review. Canadian Urological Association Journal, 9, E306-E309. [Google Scholar] [CrossRef] [PubMed]
[23] Koyama, J., Namiki, S., Kudo, T., Aizawa, M., Ioritani, N. and Nakamura, Y. (2019) Typical Type Cystitis Glandularis Presenting Urinary Retention in a Young Man: Adjuvant Therapy Using Oral Cyclooxygenase-2 Inhibitor: A Case Report. Nihon Hinyokika Gakkai Zasshi, 110, 148-151. (In Japanese) [Google Scholar] [CrossRef] [PubMed]
[24] Ni, Y., Zhao, S., Yin, X., Wang, H., Guang, Q., Hu, G., Yang, Y., Jiao, S. and Shi, B. (2017) Intravesicular Administration of Sodium Hyaluronate Ameliorates the Inflammation and Cell Proliferation of Cystitis Cystica et Glandularis Involving Interleukin-6/JAK2/Stat3 Signaling Pathway. Scientific Reports, 7, Article No.15892. [Google Scholar] [CrossRef] [PubMed]
[25] Ballas, K., Rafailidis, S., Pavlidis, T., Marakis, G., Psarras, K., Anagnostara, E. and Sakadamis, A. (2007) Gangrenous Cystitis. International Urogynecology Journal, 18, 1507-1509. [Google Scholar] [CrossRef] [PubMed]
[26] Elalaoui, A., Elmoudane, A., Mokhtari, M., Elfarhaoui, H., Motaouakil, A. and Barki, A. (2022) Rare Case of Gangrenous Cystitis Revealed by Acute Peritonitis. Urology Case Reports, 45, Article 102239. [Google Scholar] [CrossRef] [PubMed]
[27] Kotoulas, K., Georgellis, C., Kigitzi, E., Liappis, A., Spounos, M., Tsalkidou, V. and Patris, E. (2018) Acute Diffuse Peritonitis Caused by Urinary Retention: A Rare Case of Gangrenous Cystitis. Case Reports in Urology, 2018, Article ID: 4948375. [Google Scholar] [CrossRef] [PubMed]
[28] Fujiwara, S., Noguchi, T., Noguchi, T., Emoto, A. and Tasaki, Y. (2008) Panperitonitis Caused by Gangrene of the Urinary Bladder: Report of a Successfully Treated Case. The American Surgeon, 74, 302-304. [Google Scholar] [CrossRef] 
[29] White, M.D., Das, A.K. and Kaufman, R.P. (1998) Gangrenous Cystitis in the Elderly: Pathogenesis and Management Options. British Journal of Urology, 82, 297-299. [Google Scholar] [CrossRef] 
[30] Thomas, A.A., Lane, B.R., Thomas, A.Z., Remer, E.M., Campbell, S.C. and Shoskes, D.A. (2007) Emphysematous Cystitis: A Review of 135 Cases. BJU International, 100, 17-20. [Google Scholar] [CrossRef] 
[31] Amano, M. and Shimizu, T. (2014) Emphysematous Cystitis: A Review of the Literature. Internal Medicine, 53, 79-82. [Google Scholar] [CrossRef] [PubMed]
[32] Huang, J.-J., Chen, K.-W. and Ruaan, M.-K. (1991) Mixed Acid Fermentation of Glucose as a Mechanism of Emphysematous Urinary Tract Infection. Journal of Urology, 146, 148-151. [Google Scholar] [CrossRef] 
[33] Hudnall, M.T., Jordan, B.J., Horowitz, J. and Kielb, S. (2019) A Case of Emphysematous Cystitis and Bladder Rupture. Urology Case Reports, 24, Article 100860. [Google Scholar] [CrossRef] [PubMed]
[34] Murata, Y., Matsuo, Y. and Hiraoka, E. (2023) Successful Conservative Management of Emphysematous Cystitis with Pneumoperitoneum: A Case Report and Literature Review. Cureus, 15, e43769. [Google Scholar] [CrossRef] [PubMed]
[35] 李小青, 朱燃培, 张华, 等. 清心莲子饮加减治疗放射性膀胱炎经验探析[J]. 中华中医药杂志, 2024, 39(2): 818-821.

为你推荐